StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

Stock analysts at StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued on Thursday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

Shares of TTOO stock opened at $0.21 on Thursday. The business has a fifty day moving average of $0.35 and a 200 day moving average of $1.64. T2 Biosystems has a 1 year low of $0.20 and a 1 year high of $6.95.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.